A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mouse lymphoma

Insights

A mutation in the regulatory subunit of cyclic adenosine 3':5'-monophosphate (cAMP)-dependent protein kinase in S49 lymphoma cells alters enzyme activity and cAMP sensitivity. This structural mutation is crucial for cAMP-mediated growth regulation and enzyme induction.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • S49 mouse lymphoma cells are a model system for studying cyclic adenosine 3':5'-monophosphate (cAMP) signaling.
  • Exogenous cAMP elicits biological effects including enzyme induction, growth inhibition, and cytolysis in wild-type S49 cells.
  • A mutant cell line, kin.A, exhibits reduced sensitivity to these cAMP-mediated effects.

Purpose of the Study:

  • To investigate the molecular basis for the reduced cAMP sensitivity in kin.A mutant S49 cells.
  • To determine the role of cAMP-dependent protein kinase in mediating cAMP's biological effects.
  • To identify the specific component of the cAMP-dependent protein kinase responsible for the altered phenotype.

Main Methods:

  • Comparison of cAMP-dependent protein kinase activity and kinetics between wild-type and kin.A cells.
  • Purification of cAMP-dependent protein kinase holoenzyme from both cell lines.
  • Heterologous reconstitution experiments using separated regulatory (R) and catalytic (C) subunits.

Main Results:

  • Kin.A cells showed a 10-fold greater apparent Ka for cAMP activation of protein kinase activity and increased thermolability compared to wild-type.
  • These altered properties were attributed to the regulatory (R) subunit of the cAMP-dependent protein kinase.
  • Reconstitution experiments confirmed that the R subunit of kin.A conferred altered cAMP affinity and heat sensitivity.

Conclusions:

  • The kin.A mutation involves a structural alteration in the gene coding for the R subunit of cAMP-dependent protein kinase.
  • This structural mutation is responsible for the observed changes in enzyme kinetics and thermolability.
  • cAMP-dependent protein kinase is essential for mediating cAMP's regulatory effects on growth and enzyme induction in S49 cells.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...